ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Olezarsen Cuts Triglycerides. Calms Pancreas. Changes Outcomes. 🧬🔥🛡️"
Episode Synopsis
🧬 New NEJM data on Olezarsen! In patients with severe hypertriglyceridemia, monthly RNA-targeted therapy delivered major triglyceride reductions (−62% to −72%) and a significant drop in acute pancreatitis risk (rate ratio 0.15). ✨ Improvements extended to ApoC-III, remnant cholesterol, and non-HDL cholesterol, with consistent benefits across both CORE-TIMI trials. 💡 A promising step forward in precision lipid therapy and pancreatitis prevention.
In God we trust